Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × AP 1903 reagent × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Cytokine Release Syndrome 2 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Neurotoxicity Syndromes 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Lymphoma 1 Lymphohistiocytosis, Hemophagocytic 1 Lymphatic Diseases 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Hodgkin Disease 1 Epstein-Barr Virus Infections 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Dexamethasone 16 Lenalidomide 12 Bortezomib 9 Cyclophosphamide 7 carfilzomib 6 Whole-Body Irradiation 6 Melphalan 6 fludarabine 5 daratumumab 5 Tacrolimus 5 Mycophenolic Acid 5 Calcium Dobesilate 5 pomalidomide 3 fludarabine phosphate 3 belantamab mafodotin 3 Radiotherapy 3 gamma-Globulins 2 elotuzumab 2 Trimethoprim, Sulfamethoxazole Drug Combination 2 Sirolimus 2 Prednisone 2 Immunoglobulins, Intravenous 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 venetoclax 1 thymoglobulin 1 siltuximab 1 poly ICLC 1 pembrolizumab 1 ixazomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡